Global Peripheral Neuritis Treatment Market, By Drug Class (Anti-Depressants, Tricyclic, Selective Serotonin/Norepinephrine Reuptake Inhibitors, Serotonin Reuptake Inhibitors, Anticonvulsants, Local Anesthesia, Analgesics, NSAID, Opioid, Steroids, Others), Application (Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) – Industry Trends and Forecast to 2029.
Peripheral Neuritis Treatment Market Analysis and Size
The peripheral neuritis treatment market is expected to grow at a significant growth rate over the forecast period. However, the negative impact of the COVID-19 outbreak might be challenging factors for the market within the forecasted period, but the market players are adopting various strategies to aid the expansion of the market.
- Data Bridge Market Research analyses that the peripheral neuritis treatment market is expected to grow at a CAGR of 3.50% during the forecast period. The “diabetic peripheral neuropathy” accounts for the largest application segment in the peripheral neuritis treatment market within the forecasted period.
Peripheral Neuritis TreatmentMarket Definition
The peripheral neuritis treatment market deals with the treatment of the disease named as peripheral neuritis. Peripheral neuritis (also referred as peripheral neuropathy) is basically a condition in which the peripheral nervous system is damaged, resulting in a failure to send signals to and from the brain, spinal cord, and other body parts. The causes for the conditions might be the physical trauma, diabetes, autoimmune diseases, and other factors.
Peripheral Neuritis Treatment Market Dynamics
Drivers
-
Growing Cases of Diabetes
The growing burden of diseases associated with peripheral neuritis especially the diabetes and other autoimmune diseases along with the increasing number of geriatric populations across the globe are the most significant factor driving the growth for this market.
Growing healthcare infrastructure is further projected to cushion the growth of the market. Moreover, the increasing awareness of about treatment options, rising disposable income and changing lifestyle also cushions the market’s growth within the forecasted period.
Opportunities
Furthermore, the few players are focusing on development of biologicals instead of synthetic drugs to treat peripheral neuritis owing to their better efficacy and less safety concerns which extend profitable opportunities to the market players in the forecast period of 2022 to 2029.
Restraints/Challenges
On the other hand, high cost associated with diagnosis procedure of peripheral neuropathy, lack of awareness and poor healthcare infrastructure expected to obstruct market growth. Also, the technological complexity and complications involved in the diagnosis of peripheral neuropathy are projected to challenge the peripheral neuritis treatment market in the forecast period of 2022-2029.
This peripheral neuritis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the peripheral neuritis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Peripheral Neuritis Treatment Market
COVID-19 has led to the lockdowns across the globe and have impacted the financial status of businesses across all sectors. The government's various strict guidelines and regulations regarding social distancing has placed an economic burden on the healthcare sector. Moreover, the pandemic has hampered the development, production, and supply of drugs and other healthcare products, and also affected growth of healthcare sector across the globe. Moreover, the decreased product demand had a negative impact on the peripheral neuritis treatment market during the forecast period.
Recent Developments
- On June 2020, Novaremed AG, a clinical-stage Swiss biopharmaceutical company, has received FDA approval for its investigational new drug (IND) application to begin a Phase II clinical study in the United States of the novel drug candidate, NRD135S.E1, for the treatment of painful diabetic peripheral neuropathy (PDPN).
Global Peripheral Neuritis Treatment Market Scope
The peripheral neuritis treatment market is segmented on the basis of drug class, application and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Class
- Anti-Depressants
- Tricyclic
- Selective Serotonin/Norepinephrine Reuptake Inhibitors
- Serotonin Reuptake Inhibitors
- Anticonvulsants
- Local Anesthesia
- Analgesics
- NSAID
- Opioid
- Steroids
- Others
On the basis of drug class, the peripheral neuritis treatment market is segmented into anti-depressants, tricyclic, selective serotonin/norepinephrine reuptake inhibitors, serotonin reuptake inhibitors, anticonvulsants, local anesthesia, analgesics, NSAID, opioid, steroids and others.
Application
- Diabetic Peripheral Neuropathy
- Chemotherapy-Induced Peripheral Neuropathy
- Idiopathic Peripheral Neuropathy
- Others
On the basis of application, the peripheral neuritis treatment market is segmented into diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, idiopathic peripheral neuropathy and others. Diabetic peripheral neuropathy is projected to grow at significant rate within the forecasted period.
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Distribution channel segment of peripheral neuritis treatment market is divided into hospital pharmacies, retail pharmacies, drug stores and online pharmacies.
Peripheral Neuritis Treatment Market Regional Analysis/Insights
The peripheral neuritis treatment market is analyzed and market size insights and trends are provided by country, drug class, application and distribution channel as referenced above.
The countries covered in the peripheral neuritis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the peripheral neuritis treatment market because of the increasing aging population and high prevalence of peripheral neuritis and availability of innovative therapeutics within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the presence of untapped opportunities due to extensive increase in healthcare infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The peripheral neuritis treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for peripheral neuritis treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the peripheral neuritis treatment market. The data is available for historic period 2010-2020.
Competitive Landscape and Peripheral Neuritis Treatment Market Share Analysis
The peripheral neuritis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to peripheral neuritis treatment market.
Some of the major players operating in the peripheral neuritis treatment market are Pfizer Inc, Assertio Holdings, Inc., Eli Lilly and Company, Honeywell International, Inc, Abbott, Bristol Myers Squibb, Cipla Limited, GlaxoSmithKline plc, Lupin, Merck and Co. Inc., Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories Ltd., Mylan NV, Johnson & Johnson Services Inc., and Teva Pharmaceutical Industries Ltd., NIHON KOHDEN CORPORATION, Drägerwerk AG & Co. KGaA and WinSanTor, Inc, among others.
SKU-